Bharat Serums and Vaccines’ antibody Covid treatment in Phase 2 trials
Covid-19 cases, especially of the Omicron variant, have been growing in the country and the number of hospitalisations could increase. Biopharmaceutical company Bharat Serums and Vaccines (BSV) has expanded its research and development facilities and capabilities, with its work on Covid-19 antibody development entering Phase 2 trials. Sanjiv Navangul, MD and CEO, BSV, said the … Read more